PD0055: A Dose-blinded Extension Study to Evaluate the Long-term Efficacy, Safety, and Tolerability of UCB0599 in Study Participants with Parkinson's Disease

Grants and Contracts Details

StatusActive
Effective start/end date6/30/236/30/25

Funding

  • UCB Biopharma SRL (Belgium): $11,695.00